Ocuphire Pharma
zeta characteristics study and fellow eye | Ocuphire Pharma
Company
Deck Type
Deck date
January 2023
Slide
12 of 31
Related slides by other companies
9 Meters Biopharma
Investor Presentation
September 2022
relative change from placebo | 9 Meters Biopharma
Aeglea BioTherapeutics
Investor Presentation
April 2023
peace phase trial mobility assessed by and | Aeglea BioTherapeutics
Myovant Sciences
Results
August 2022
majority of women treated with who used at were free at week | Myovant Sciences
Aeglea BioTherapeutics
Investor Presentation
May 2023
peace phase trial mobility assessed by and | Aeglea BioTherapeutics
Other recent decks by Ocuphire Pharma
See all presentations (10 decks)
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
May 2023
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights